Pulmonary disease caused by Candida species

Area of Science:

• Medical Mycology
• Pulmonary Medicine
• Infectious Diseases

Background:

• Candida species are commonly detected in sputum.
• Their role in pulmonary disease is often considered, especially in immunocompromised patients.
• Risk factors include immunosuppression and prolonged antimicrobial use.

Purpose of the Study:

• To evaluate the clinical significance of Candida pulmonary infections.
• To determine the incidence and routes of Candida lung infections in hospitalized patients.

Main Methods:

• Retrospective review of 30 patients with histologic evidence of Candida pulmonary infection over two years.
• Analysis of infection routes (hematogenous spread, aspiration) and patient demographics.
• Assessment of Candida pulmonary disease as a clinical factor.

Main Results:

• Pulmonary infections occurred via hematogenous spread (10 patients) and aspiration (16 patients).
• Most patients had underlying malignant neoplastic disease.
• Candida pulmonary disease was a significant factor in only three cases.

Conclusions:

• Candida species infrequently cause significant pulmonary disease.
• Extensive Candida lung involvement is usually seen in critically ill patients with multiple comorbidities.
• The clinical impact of Candida in pulmonary specimens is often limited.